A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
GC Cell Corporation
Acepodia Biotech, Inc.
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
Technical University of Munich
City of Hope Medical Center
Rutgers, The State University of New Jersey
Cancer Research UK